Back

Results - Announcements

Sales rise 14.08% to Rs 1190.39 crore

Strides Pharma Science consolidated net profit rises 352.09% in the March 2025 quarter

22-May-2025, 03:16
Net profit of Strides Pharma Science rose 352.09% to Rs 82.19 crore in the quarter ended March 2025 as against Rs 18.18 crore during the previous quarter ended March 2024. Sales rose 14.08% to Rs 1190.39 crore in the quarter ended March 2025 as against Rs 1043.50 crore during the previous quarter ended March 2024.

For the full year,net profit reported to Rs 3593.46 crore in the year ended March 2025 as against net loss of Rs 70.62 crore during the previous year ended March 2024. Sales rose 17.36% to Rs 4565.34 crore in the year ended March 2025 as against Rs 3890.13 crore during the previous year ended March 2024.

Particulars	Quarter Ended			Year Ended
	Mar. 2025	Mar. 2024	% Var.	Mar. 2025	Mar. 2024	% Var.
Sales	1190.39	1043.50	14	4565.34	3890.13	17
OPM %	18.30	16.23	-	17.58	13.58	-
PBDT	182.66	84.69	116	614.52	287.89	113
PBT	133.80	36.76	264	422.26	74.25	469
NP	82.19	18.18	352	3593.46	-70.62	LP